DUBLIN and BRIDGEWATER, N.J., March 12, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN), today announced financial results for the fourth quarter of 2024 and provided a review of fourth ...
Amarin incurs a wider-than-expected loss in Q4. Revenues beat estimates. It plans to initiate a ratio change on its American Depositary Shares. Stock falls.
Amarin Corporation reported Q4 2024 revenues of $62.3 million, with operating expenses of $43 million and significant global growth in VASCEPA. Operating expenses decreased to $43.0 million ...
3d
No fractional new ADSs will be issued in connection with the Ratio Change. Rather, fractional entitlements to new ADSs will be aggregated and sold by the depositary bank, and the net cash proceeds ...
Despite exceeding Street forecasts with its Q4 2024 financials, Amarin Corporation (NASDAQ:AMRN) traded lower in the premarket on Wednesday as the Irish biotech announced plans to implement a ...
Amarin Corporation plc has announced a planned change in the ratio of its American Depositary Shares (ADS) beginning around April 11, 2025, adjusting from one ADS representing one ordinary share ...
Amarin (NASDAQ:AMRN – Get Free Report) will likely be posting its quarterly earnings results before the market opens on Wednesday, March 12th. Analysts expect Amarin to post earnings of ($0.06) per ...
Welcome to Amarin Corporation's Conference Call to discuss its Fourth Quarter and Full Year 2024 Business Update and Financial Results. I would like to turn the conference call over to Mark Marmur ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback